Home > National Drug Code (NDC) > Carbidopa and Levodopa

Carbidopa and Levodopa - 76237-130-30 - (Carbidopa and Levodopa)

Alphabetical Index


Drug Information of Carbidopa and Levodopa

Product NDC: 76237-130
Proprietary Name: Carbidopa and Levodopa
Non Proprietary Name: Carbidopa and Levodopa
Active Ingredient(s): 25; 250    mg/1; mg/1 & nbsp;   Carbidopa and Levodopa
Administration Route(s): ORAL
Dosage Form(s): TABLET
Coding System: National Drug Codes(NDC)

Labeler Information of Carbidopa and Levodopa

Product NDC: 76237-130
Labeler Name: McKesson Contract Packaging
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA074260
Marketing Category: ANDA
Start Marketing Date: 20111221

Package Information of Carbidopa and Levodopa

Package NDC: 76237-130-30
Package Description: 6 BLISTER PACK in 1 BOX, UNIT-DOSE (76237-130-30) > 5 TABLET in 1 BLISTER PACK

NDC Information of Carbidopa and Levodopa

NDC Code 76237-130-30
Proprietary Name Carbidopa and Levodopa
Package Description 6 BLISTER PACK in 1 BOX, UNIT-DOSE (76237-130-30) > 5 TABLET in 1 BLISTER PACK
Product NDC 76237-130
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Carbidopa and Levodopa
Dosage Form Name TABLET
Route Name ORAL
Start Marketing Date 20111221
Marketing Category Name ANDA
Labeler Name McKesson Contract Packaging
Substance Name CARBIDOPA; LEVODOPA
Strength Number 25; 250
Strength Unit mg/1; mg/1
Pharmaceutical Classes Aromatic Amino Acid Decarboxylation Inhibitor [EPC],DOPA Decarboxylase Inhibitors [MoA],Aromatic Amino Acid Decarboxylation Inhibitor [EPC],DOPA Decarboxylase Inhibitors [MoA]

Complete Information of Carbidopa and Levodopa


General Information